EGFR and non-small cell lung carcinoma: This evidence is in line with our findings, as we observed that the EGFR-mutant NSCLC cell line H1975 accumulated in G2–M, slowed down its in culture proliferation ability, and showed tumor growth inhibition in xenograft models, upon treatment with Unesbulin.